Acer Therapeutics Inc (ACER)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2012 | 03-2012 | 12-2011 | 09-2011 | 06-2011 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -4,539 | -2,374 | -5,968 | -4,091 | -2,794 |
| Depreciation Amortization | 144 | 67 | 210 | 157 | 100 |
| Accounts payable and accrued liabilities | 52 | 1,023 | -13 | 60 | 101 |
| Other Working Capital | -1,043 | -84 | 183 | -10 | -31 |
| Other Operating Activity | 319 | -817 | 600 | 413 | 278 |
| Operating Cash Flow | $-5,066 | $-2,185 | $-4,989 | $-3,471 | $-2,346 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -473 | -246 | -297 | -284 | -172 |
| Investing Cash Flow | $-473 | $-246 | $-297 | $-284 | $-172 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | N/A | N/A | -36 | N/A | N/A |
| Common Stock Issued | N/A | N/A | 8,618 | 8,618 | 8,618 |
| Other Financing Activity | 0 | 0 | 0 | -36 | -36 |
| Financing Cash Flow | $N/A | $N/A | $8,583 | $8,583 | $8,583 |
| Beginning Cash Position | 7,109 | 7,109 | 3,813 | 3,813 | 3,813 |
| End Cash Position | 1,570 | 4,678 | 7,109 | 8,640 | 9,877 |
| Net Cash Flow | $-5,539 | $-2,431 | $3,297 | $4,827 | $6,064 |
| Free Cash Flow | |||||
| Operating Cash Flow | -5,066 | -2,185 | -4,989 | -3,471 | -2,346 |
| Capital Expenditure | -473 | -246 | -297 | -284 | -172 |
| Free Cash Flow | -5,539 | -2,431 | -5,286 | -3,755 | -2,519 |